APA Citatie

Girard, A. E., Girard, D., Gootz, T. D., Faiella, J. A., & Cimochowski, C. R. (1995). In vivo efficacy of trovafloxacin (CP-99,219), a new quinolone with extended activities against gram-positive pathogens, Streptococcus pneumoniae, and Bacteroides fragilis.

Chicago Style citaat

Girard, A E., D. Girard, T D. Gootz, J A. Faiella, en C R. Cimochowski. In Vivo Efficacy of Trovafloxacin (CP-99,219), a New Quinolone With Extended Activities against Gram-positive Pathogens, Streptococcus Pneumoniae, and Bacteroides Fragilis. 1995.

MLA citatie

Girard, A E., et al. In Vivo Efficacy of Trovafloxacin (CP-99,219), a New Quinolone With Extended Activities against Gram-positive Pathogens, Streptococcus Pneumoniae, and Bacteroides Fragilis. 1995.